UT MD Anderson Article Offers One Roadmap for Defining Value in Health Care, Earns National Award fr...
Christopher Flowers, M.D., division head ad interim of Cancer Medicine and chair of Lymphoma & Myeloma at The University of Texas MD Anderson Cancer Center, has received a 2022 ASH Mentor Award from the American Society of Hematology in acknowledgement of his career-long commitment to mentoring.
The University of Texas MD Anderson Cancer Center and World Health Organization (WHO) today announced a formal agreement to establish a new international collaboration concentrated on reducing the global burden of women’s cancers. The agreement builds on years of collaboration between the two institutions to further promote their shared efforts in advancing global cancer initiatives in women’s cancers, including breast and cervical cancers.
In recognition of her trailblazing work uncovering the mechanisms of the p53 tumor suppressor, Guillermina “Gigi” Lozano, Ph.D., chair of Genetics at The University of Texas MD Anderson Cancer Center, has received the 2022 Award for Distinguished Research in the Biomedical Sciences by the Association of American Medical Colleges (AAMC).
MD Anderson today announced that Donna Hansel, M.D., Ph.D., has been named Division Head of Pathology and Laboratory Medicine. A distinguished pathologist, researcher and leader, Hansel will join MD Anderson Sept. 12.
Cancer cells often delete genes that normally suppress tumor formation. These deletions also may extend to neighboring genes, an event known as “collateral lethality,” which may create new options for development of therapies for several cancers.
HOUSTON - The American Society of Clinical Oncology (ASCO) will present the 2023 David A. Karnofsky Memorial Award to Hagop Kantarjian, M.D., chair of Leukemia at The University of Texas MD Anderson Cancer Center, for his contributions to leukemia clinical research and his dedication to improving the lives of patients.
Anderson Algorithm increases surgical success with advanced ovarian cancer | MD Anderson Cancer Cent...
Cord blood-derived natural killer cells combined with a bispecific antibody displayed potent activity against lymphoma cells in a preclinical study led by MD Anderson researchers.
APBI Brachytherapy Associated with Higher Rate of Later Mastectomy, Increased Toxicities, Post-Op Co...